JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1081922, encodeId=0366108192243, content=偏重的研究方向：肿瘤 经验分享：我的文章13号接收的，回来看评论，很多朋友都在问参考文献格式怎么下，说实话，到现在文章被接收我都不知道哪里下，我当时投稿的时候也是找了半天没找到，后来索性找了个施普林格旗下比较类似的文献格式，然后用endnote编辑成JOCR这个样子的，然后投稿了，到现在接收了也没有什么问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5bc5555629, createdName=解忧, createdTime=Sun Dec 19 22:32:54 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218438, encodeId=49f11218438ff, content=偏重的研究方向：肿瘤;眼科 经验分享：2022.5.5晚10点投稿 2022.5.6 Quality check passed , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d564883189, createdName=18344b9fa1m, createdTime=Tue May 10 13:43:22 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115429, encodeId=695221154290a, content=偏重的研究方向：肿瘤学;肝癌 经验分享：这个接收之后多久通知排版交钱啊，多久能见刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea6a8386516, createdName=ms3000002119116075, createdTime=Sun Feb 19 20:04:31 CST 2023, time=2023-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113511, encodeId=75e8211351115, content=偏重的研究方向：肿瘤 经验分享：这个杂志最近是不是有点慢啊，12.21 1 reviewer accepted，1.7 2reviewers accepted，然后就没有动静了，要不要写信催一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc268448312, createdName=ms1000000584175178, createdTime=Tue Feb 07 18:01:05 CST 2023, time=2023-02-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2104949, encodeId=30da210494901, content=偏重的研究方向：肿瘤 经验分享：11.29投稿，现在还在editor appointed……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc268448312, createdName=ms1000000584175178, createdTime=Thu Dec 08 17:36:58 CST 2022, time=2022-12-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2113155, encodeId=88c12113155d5, content=偏重的研究方向：肿瘤 经验分享：这个期刊发出去的推荐审稿邮件怎么总是接收不到啊，大家有这个情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea6a8386516, createdName=ms3000002119116075, createdTime=Sun Feb 05 18:21:05 CST 2023, time=2023-02-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113154, encodeId=9765211315416, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：为什么这个期刊发出去的邀请审稿的邮件都收不到啊，我推荐的审稿人编辑表示已经邀请了，但是人家说没收到邮件。奇怪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea6a8386516, createdName=ms3000002119116075, createdTime=Sun Feb 05 18:09:47 CST 2023, time=2023-02-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2111036, encodeId=2cfe2111036f7, content=好慢啊，无语了，两个月还没有修回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff96408430, createdName=ms5000000443448137, createdTime=Fri Jan 20 23:58:25 CST 2023, time=2023-01-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2104156, encodeId=286b210415611, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：有大佬知道为啥我的技术审核那步一个月了没动静。问编辑，编辑说没收到任何投稿。这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d688419494, createdName=ms4000002066444752, createdTime=Sat Dec 03 22:47:34 CST 2022, time=2022-12-03, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1240483, encodeId=d085124048302, content=除了大修过程中出了一点小问题，没收到修稿邮件沟通了10天左右，其他的还是挺快的，文章已接收，可以毕业啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=231b6472494, createdName=ms3000000539853394, createdTime=Tue Aug 23 10:55:35 CST 2022, time=2022-08-23, status=1, ipAttribution=)]

2021-12-19 解忧

偏重的研究方向：肿瘤
经验分享：我的文章13号接收的，回来看评论，很多朋友都在问参考文献格式怎么下，说实话，到现在文章被接收我都不知道哪里下，我当时投稿的时候也是找了半天没找到，后来索性找了个施普林格旗下比较类似的文献格式，然后用endnote编辑成JOCR这个样子的，然后投稿了，到现在接收了也没有什么问题

6 32

展开32条回复

[GetPortalCommentsPageByObjectIdResponse(id=1081922, encodeId=0366108192243, content=偏重的研究方向：肿瘤 经验分享：我的文章13号接收的，回来看评论，很多朋友都在问参考文献格式怎么下，说实话，到现在文章被接收我都不知道哪里下，我当时投稿的时候也是找了半天没找到，后来索性找了个施普林格旗下比较类似的文献格式，然后用endnote编辑成JOCR这个样子的，然后投稿了，到现在接收了也没有什么问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5bc5555629, createdName=解忧, createdTime=Sun Dec 19 22:32:54 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218438, encodeId=49f11218438ff, content=偏重的研究方向：肿瘤;眼科 经验分享：2022.5.5晚10点投稿 2022.5.6 Quality check passed , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d564883189, createdName=18344b9fa1m, createdTime=Tue May 10 13:43:22 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115429, encodeId=695221154290a, content=偏重的研究方向：肿瘤学;肝癌 经验分享：这个接收之后多久通知排版交钱啊，多久能见刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea6a8386516, createdName=ms3000002119116075, createdTime=Sun Feb 19 20:04:31 CST 2023, time=2023-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113511, encodeId=75e8211351115, content=偏重的研究方向：肿瘤 经验分享：这个杂志最近是不是有点慢啊，12.21 1 reviewer accepted，1.7 2reviewers accepted，然后就没有动静了，要不要写信催一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc268448312, createdName=ms1000000584175178, createdTime=Tue Feb 07 18:01:05 CST 2023, time=2023-02-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2104949, encodeId=30da210494901, content=偏重的研究方向：肿瘤 经验分享：11.29投稿，现在还在editor appointed……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc268448312, createdName=ms1000000584175178, createdTime=Thu Dec 08 17:36:58 CST 2022, time=2022-12-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2113155, encodeId=88c12113155d5, content=偏重的研究方向：肿瘤 经验分享：这个期刊发出去的推荐审稿邮件怎么总是接收不到啊，大家有这个情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea6a8386516, createdName=ms3000002119116075, createdTime=Sun Feb 05 18:21:05 CST 2023, time=2023-02-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113154, encodeId=9765211315416, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：为什么这个期刊发出去的邀请审稿的邮件都收不到啊，我推荐的审稿人编辑表示已经邀请了，但是人家说没收到邮件。奇怪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea6a8386516, createdName=ms3000002119116075, createdTime=Sun Feb 05 18:09:47 CST 2023, time=2023-02-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2111036, encodeId=2cfe2111036f7, content=好慢啊，无语了，两个月还没有修回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff96408430, createdName=ms5000000443448137, createdTime=Fri Jan 20 23:58:25 CST 2023, time=2023-01-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2104156, encodeId=286b210415611, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：有大佬知道为啥我的技术审核那步一个月了没动静。问编辑，编辑说没收到任何投稿。这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d688419494, createdName=ms4000002066444752, createdTime=Sat Dec 03 22:47:34 CST 2022, time=2022-12-03, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1240483, encodeId=d085124048302, content=除了大修过程中出了一点小问题，没收到修稿邮件沟通了10天左右，其他的还是挺快的，文章已接收，可以毕业啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=231b6472494, createdName=ms3000000539853394, createdTime=Tue Aug 23 10:55:35 CST 2022, time=2022-08-23, status=1, ipAttribution=)]

2022-05-10 18344b9fa1m

偏重的研究方向：肿瘤;眼科
经验分享：2022.5.5晚10点投稿
2022.5.6 Quality check passed

56 31

展开31条回复

[GetPortalCommentsPageByObjectIdResponse(id=1081922, encodeId=0366108192243, content=偏重的研究方向：肿瘤 经验分享：我的文章13号接收的，回来看评论，很多朋友都在问参考文献格式怎么下，说实话，到现在文章被接收我都不知道哪里下，我当时投稿的时候也是找了半天没找到，后来索性找了个施普林格旗下比较类似的文献格式，然后用endnote编辑成JOCR这个样子的，然后投稿了，到现在接收了也没有什么问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5bc5555629, createdName=解忧, createdTime=Sun Dec 19 22:32:54 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218438, encodeId=49f11218438ff, content=偏重的研究方向：肿瘤;眼科 经验分享：2022.5.5晚10点投稿 2022.5.6 Quality check passed , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d564883189, createdName=18344b9fa1m, createdTime=Tue May 10 13:43:22 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115429, encodeId=695221154290a, content=偏重的研究方向：肿瘤学;肝癌 经验分享：这个接收之后多久通知排版交钱啊，多久能见刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea6a8386516, createdName=ms3000002119116075, createdTime=Sun Feb 19 20:04:31 CST 2023, time=2023-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113511, encodeId=75e8211351115, content=偏重的研究方向：肿瘤 经验分享：这个杂志最近是不是有点慢啊，12.21 1 reviewer accepted，1.7 2reviewers accepted，然后就没有动静了，要不要写信催一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc268448312, createdName=ms1000000584175178, createdTime=Tue Feb 07 18:01:05 CST 2023, time=2023-02-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2104949, encodeId=30da210494901, content=偏重的研究方向：肿瘤 经验分享：11.29投稿，现在还在editor appointed……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc268448312, createdName=ms1000000584175178, createdTime=Thu Dec 08 17:36:58 CST 2022, time=2022-12-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2113155, encodeId=88c12113155d5, content=偏重的研究方向：肿瘤 经验分享：这个期刊发出去的推荐审稿邮件怎么总是接收不到啊，大家有这个情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea6a8386516, createdName=ms3000002119116075, createdTime=Sun Feb 05 18:21:05 CST 2023, time=2023-02-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113154, encodeId=9765211315416, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：为什么这个期刊发出去的邀请审稿的邮件都收不到啊，我推荐的审稿人编辑表示已经邀请了，但是人家说没收到邮件。奇怪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea6a8386516, createdName=ms3000002119116075, createdTime=Sun Feb 05 18:09:47 CST 2023, time=2023-02-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2111036, encodeId=2cfe2111036f7, content=好慢啊，无语了，两个月还没有修回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff96408430, createdName=ms5000000443448137, createdTime=Fri Jan 20 23:58:25 CST 2023, time=2023-01-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2104156, encodeId=286b210415611, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：有大佬知道为啥我的技术审核那步一个月了没动静。问编辑，编辑说没收到任何投稿。这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d688419494, createdName=ms4000002066444752, createdTime=Sat Dec 03 22:47:34 CST 2022, time=2022-12-03, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1240483, encodeId=d085124048302, content=除了大修过程中出了一点小问题，没收到修稿邮件沟通了10天左右，其他的还是挺快的，文章已接收，可以毕业啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=231b6472494, createdName=ms3000000539853394, createdTime=Tue Aug 23 10:55:35 CST 2022, time=2022-08-23, status=1, ipAttribution=)]

2023-02-19 ms3000002119116075 来自上海

偏重的研究方向：肿瘤学;肝癌
经验分享：这个接收之后多久通知排版交钱啊，多久能见刊啊

36 0

[GetPortalCommentsPageByObjectIdResponse(id=1081922, encodeId=0366108192243, content=偏重的研究方向：肿瘤 经验分享：我的文章13号接收的，回来看评论，很多朋友都在问参考文献格式怎么下，说实话，到现在文章被接收我都不知道哪里下，我当时投稿的时候也是找了半天没找到，后来索性找了个施普林格旗下比较类似的文献格式，然后用endnote编辑成JOCR这个样子的，然后投稿了，到现在接收了也没有什么问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5bc5555629, createdName=解忧, createdTime=Sun Dec 19 22:32:54 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218438, encodeId=49f11218438ff, content=偏重的研究方向：肿瘤;眼科 经验分享：2022.5.5晚10点投稿 2022.5.6 Quality check passed , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d564883189, createdName=18344b9fa1m, createdTime=Tue May 10 13:43:22 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115429, encodeId=695221154290a, content=偏重的研究方向：肿瘤学;肝癌 经验分享：这个接收之后多久通知排版交钱啊，多久能见刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea6a8386516, createdName=ms3000002119116075, createdTime=Sun Feb 19 20:04:31 CST 2023, time=2023-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113511, encodeId=75e8211351115, content=偏重的研究方向：肿瘤 经验分享：这个杂志最近是不是有点慢啊，12.21 1 reviewer accepted，1.7 2reviewers accepted，然后就没有动静了，要不要写信催一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc268448312, createdName=ms1000000584175178, createdTime=Tue Feb 07 18:01:05 CST 2023, time=2023-02-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2104949, encodeId=30da210494901, content=偏重的研究方向：肿瘤 经验分享：11.29投稿，现在还在editor appointed……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc268448312, createdName=ms1000000584175178, createdTime=Thu Dec 08 17:36:58 CST 2022, time=2022-12-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2113155, encodeId=88c12113155d5, content=偏重的研究方向：肿瘤 经验分享：这个期刊发出去的推荐审稿邮件怎么总是接收不到啊，大家有这个情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea6a8386516, createdName=ms3000002119116075, createdTime=Sun Feb 05 18:21:05 CST 2023, time=2023-02-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113154, encodeId=9765211315416, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：为什么这个期刊发出去的邀请审稿的邮件都收不到啊，我推荐的审稿人编辑表示已经邀请了，但是人家说没收到邮件。奇怪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea6a8386516, createdName=ms3000002119116075, createdTime=Sun Feb 05 18:09:47 CST 2023, time=2023-02-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2111036, encodeId=2cfe2111036f7, content=好慢啊，无语了，两个月还没有修回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff96408430, createdName=ms5000000443448137, createdTime=Fri Jan 20 23:58:25 CST 2023, time=2023-01-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2104156, encodeId=286b210415611, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：有大佬知道为啥我的技术审核那步一个月了没动静。问编辑，编辑说没收到任何投稿。这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d688419494, createdName=ms4000002066444752, createdTime=Sat Dec 03 22:47:34 CST 2022, time=2022-12-03, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1240483, encodeId=d085124048302, content=除了大修过程中出了一点小问题，没收到修稿邮件沟通了10天左右，其他的还是挺快的，文章已接收，可以毕业啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=231b6472494, createdName=ms3000000539853394, createdTime=Tue Aug 23 10:55:35 CST 2022, time=2022-08-23, status=1, ipAttribution=)]

2023-02-07 ms1000000584175178 来自河南省

偏重的研究方向：肿瘤
经验分享：这个杂志最近是不是有点慢啊，12.21 1 reviewer accepted，1.7 2reviewers accepted，然后就没有动静了，要不要写信催一下

35 0

[GetPortalCommentsPageByObjectIdResponse(id=1081922, encodeId=0366108192243, content=偏重的研究方向：肿瘤 经验分享：我的文章13号接收的，回来看评论，很多朋友都在问参考文献格式怎么下，说实话，到现在文章被接收我都不知道哪里下，我当时投稿的时候也是找了半天没找到，后来索性找了个施普林格旗下比较类似的文献格式，然后用endnote编辑成JOCR这个样子的，然后投稿了，到现在接收了也没有什么问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5bc5555629, createdName=解忧, createdTime=Sun Dec 19 22:32:54 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218438, encodeId=49f11218438ff, content=偏重的研究方向：肿瘤;眼科 经验分享：2022.5.5晚10点投稿 2022.5.6 Quality check passed , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d564883189, createdName=18344b9fa1m, createdTime=Tue May 10 13:43:22 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115429, encodeId=695221154290a, content=偏重的研究方向：肿瘤学;肝癌 经验分享：这个接收之后多久通知排版交钱啊，多久能见刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea6a8386516, createdName=ms3000002119116075, createdTime=Sun Feb 19 20:04:31 CST 2023, time=2023-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113511, encodeId=75e8211351115, content=偏重的研究方向：肿瘤 经验分享：这个杂志最近是不是有点慢啊，12.21 1 reviewer accepted，1.7 2reviewers accepted，然后就没有动静了，要不要写信催一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc268448312, createdName=ms1000000584175178, createdTime=Tue Feb 07 18:01:05 CST 2023, time=2023-02-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2104949, encodeId=30da210494901, content=偏重的研究方向：肿瘤 经验分享：11.29投稿，现在还在editor appointed……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc268448312, createdName=ms1000000584175178, createdTime=Thu Dec 08 17:36:58 CST 2022, time=2022-12-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2113155, encodeId=88c12113155d5, content=偏重的研究方向：肿瘤 经验分享：这个期刊发出去的推荐审稿邮件怎么总是接收不到啊，大家有这个情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea6a8386516, createdName=ms3000002119116075, createdTime=Sun Feb 05 18:21:05 CST 2023, time=2023-02-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113154, encodeId=9765211315416, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：为什么这个期刊发出去的邀请审稿的邮件都收不到啊，我推荐的审稿人编辑表示已经邀请了，但是人家说没收到邮件。奇怪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea6a8386516, createdName=ms3000002119116075, createdTime=Sun Feb 05 18:09:47 CST 2023, time=2023-02-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2111036, encodeId=2cfe2111036f7, content=好慢啊，无语了，两个月还没有修回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff96408430, createdName=ms5000000443448137, createdTime=Fri Jan 20 23:58:25 CST 2023, time=2023-01-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2104156, encodeId=286b210415611, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：有大佬知道为啥我的技术审核那步一个月了没动静。问编辑，编辑说没收到任何投稿。这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d688419494, createdName=ms4000002066444752, createdTime=Sat Dec 03 22:47:34 CST 2022, time=2022-12-03, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1240483, encodeId=d085124048302, content=除了大修过程中出了一点小问题，没收到修稿邮件沟通了10天左右，其他的还是挺快的，文章已接收，可以毕业啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=231b6472494, createdName=ms3000000539853394, createdTime=Tue Aug 23 10:55:35 CST 2022, time=2022-08-23, status=1, ipAttribution=)]

2022-12-08 ms1000000584175178 来自河南省

偏重的研究方向：肿瘤
经验分享：11.29投稿，现在还在editor appointed……

43 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1081922, encodeId=0366108192243, content=偏重的研究方向：肿瘤 经验分享：我的文章13号接收的，回来看评论，很多朋友都在问参考文献格式怎么下，说实话，到现在文章被接收我都不知道哪里下，我当时投稿的时候也是找了半天没找到，后来索性找了个施普林格旗下比较类似的文献格式，然后用endnote编辑成JOCR这个样子的，然后投稿了，到现在接收了也没有什么问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5bc5555629, createdName=解忧, createdTime=Sun Dec 19 22:32:54 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218438, encodeId=49f11218438ff, content=偏重的研究方向：肿瘤;眼科 经验分享：2022.5.5晚10点投稿 2022.5.6 Quality check passed , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d564883189, createdName=18344b9fa1m, createdTime=Tue May 10 13:43:22 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115429, encodeId=695221154290a, content=偏重的研究方向：肿瘤学;肝癌 经验分享：这个接收之后多久通知排版交钱啊，多久能见刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea6a8386516, createdName=ms3000002119116075, createdTime=Sun Feb 19 20:04:31 CST 2023, time=2023-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113511, encodeId=75e8211351115, content=偏重的研究方向：肿瘤 经验分享：这个杂志最近是不是有点慢啊，12.21 1 reviewer accepted，1.7 2reviewers accepted，然后就没有动静了，要不要写信催一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc268448312, createdName=ms1000000584175178, createdTime=Tue Feb 07 18:01:05 CST 2023, time=2023-02-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2104949, encodeId=30da210494901, content=偏重的研究方向：肿瘤 经验分享：11.29投稿，现在还在editor appointed……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc268448312, createdName=ms1000000584175178, createdTime=Thu Dec 08 17:36:58 CST 2022, time=2022-12-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2113155, encodeId=88c12113155d5, content=偏重的研究方向：肿瘤 经验分享：这个期刊发出去的推荐审稿邮件怎么总是接收不到啊，大家有这个情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea6a8386516, createdName=ms3000002119116075, createdTime=Sun Feb 05 18:21:05 CST 2023, time=2023-02-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113154, encodeId=9765211315416, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：为什么这个期刊发出去的邀请审稿的邮件都收不到啊，我推荐的审稿人编辑表示已经邀请了，但是人家说没收到邮件。奇怪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea6a8386516, createdName=ms3000002119116075, createdTime=Sun Feb 05 18:09:47 CST 2023, time=2023-02-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2111036, encodeId=2cfe2111036f7, content=好慢啊，无语了，两个月还没有修回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff96408430, createdName=ms5000000443448137, createdTime=Fri Jan 20 23:58:25 CST 2023, time=2023-01-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2104156, encodeId=286b210415611, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：有大佬知道为啥我的技术审核那步一个月了没动静。问编辑，编辑说没收到任何投稿。这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d688419494, createdName=ms4000002066444752, createdTime=Sat Dec 03 22:47:34 CST 2022, time=2022-12-03, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1240483, encodeId=d085124048302, content=除了大修过程中出了一点小问题，没收到修稿邮件沟通了10天左右，其他的还是挺快的，文章已接收，可以毕业啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=231b6472494, createdName=ms3000000539853394, createdTime=Tue Aug 23 10:55:35 CST 2022, time=2022-08-23, status=1, ipAttribution=)]

2023-02-05 ms3000002119116075 来自上海

偏重的研究方向：肿瘤
经验分享：这个期刊发出去的推荐审稿邮件怎么总是接收不到啊，大家有这个情况吗

23 0

[GetPortalCommentsPageByObjectIdResponse(id=1081922, encodeId=0366108192243, content=偏重的研究方向：肿瘤 经验分享：我的文章13号接收的，回来看评论，很多朋友都在问参考文献格式怎么下，说实话，到现在文章被接收我都不知道哪里下，我当时投稿的时候也是找了半天没找到，后来索性找了个施普林格旗下比较类似的文献格式，然后用endnote编辑成JOCR这个样子的，然后投稿了，到现在接收了也没有什么问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5bc5555629, createdName=解忧, createdTime=Sun Dec 19 22:32:54 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218438, encodeId=49f11218438ff, content=偏重的研究方向：肿瘤;眼科 经验分享：2022.5.5晚10点投稿 2022.5.6 Quality check passed , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d564883189, createdName=18344b9fa1m, createdTime=Tue May 10 13:43:22 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115429, encodeId=695221154290a, content=偏重的研究方向：肿瘤学;肝癌 经验分享：这个接收之后多久通知排版交钱啊，多久能见刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea6a8386516, createdName=ms3000002119116075, createdTime=Sun Feb 19 20:04:31 CST 2023, time=2023-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113511, encodeId=75e8211351115, content=偏重的研究方向：肿瘤 经验分享：这个杂志最近是不是有点慢啊，12.21 1 reviewer accepted，1.7 2reviewers accepted，然后就没有动静了，要不要写信催一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc268448312, createdName=ms1000000584175178, createdTime=Tue Feb 07 18:01:05 CST 2023, time=2023-02-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2104949, encodeId=30da210494901, content=偏重的研究方向：肿瘤 经验分享：11.29投稿，现在还在editor appointed……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc268448312, createdName=ms1000000584175178, createdTime=Thu Dec 08 17:36:58 CST 2022, time=2022-12-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2113155, encodeId=88c12113155d5, content=偏重的研究方向：肿瘤 经验分享：这个期刊发出去的推荐审稿邮件怎么总是接收不到啊，大家有这个情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea6a8386516, createdName=ms3000002119116075, createdTime=Sun Feb 05 18:21:05 CST 2023, time=2023-02-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113154, encodeId=9765211315416, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：为什么这个期刊发出去的邀请审稿的邮件都收不到啊，我推荐的审稿人编辑表示已经邀请了，但是人家说没收到邮件。奇怪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea6a8386516, createdName=ms3000002119116075, createdTime=Sun Feb 05 18:09:47 CST 2023, time=2023-02-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2111036, encodeId=2cfe2111036f7, content=好慢啊，无语了，两个月还没有修回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff96408430, createdName=ms5000000443448137, createdTime=Fri Jan 20 23:58:25 CST 2023, time=2023-01-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2104156, encodeId=286b210415611, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：有大佬知道为啥我的技术审核那步一个月了没动静。问编辑，编辑说没收到任何投稿。这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d688419494, createdName=ms4000002066444752, createdTime=Sat Dec 03 22:47:34 CST 2022, time=2022-12-03, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1240483, encodeId=d085124048302, content=除了大修过程中出了一点小问题，没收到修稿邮件沟通了10天左右，其他的还是挺快的，文章已接收，可以毕业啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=231b6472494, createdName=ms3000000539853394, createdTime=Tue Aug 23 10:55:35 CST 2022, time=2022-08-23, status=1, ipAttribution=)]

2023-02-05 ms3000002119116075 来自上海

审稿速度:2.0 | 投稿命中率:50.0
经验分享：为什么这个期刊发出去的邀请审稿的邮件都收不到啊，我推荐的审稿人编辑表示已经邀请了，但是人家说没收到邮件。奇怪

0 0

[GetPortalCommentsPageByObjectIdResponse(id=1081922, encodeId=0366108192243, content=偏重的研究方向：肿瘤 经验分享：我的文章13号接收的，回来看评论，很多朋友都在问参考文献格式怎么下，说实话，到现在文章被接收我都不知道哪里下，我当时投稿的时候也是找了半天没找到，后来索性找了个施普林格旗下比较类似的文献格式，然后用endnote编辑成JOCR这个样子的，然后投稿了，到现在接收了也没有什么问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5bc5555629, createdName=解忧, createdTime=Sun Dec 19 22:32:54 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218438, encodeId=49f11218438ff, content=偏重的研究方向：肿瘤;眼科 经验分享：2022.5.5晚10点投稿 2022.5.6 Quality check passed , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d564883189, createdName=18344b9fa1m, createdTime=Tue May 10 13:43:22 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115429, encodeId=695221154290a, content=偏重的研究方向：肿瘤学;肝癌 经验分享：这个接收之后多久通知排版交钱啊，多久能见刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea6a8386516, createdName=ms3000002119116075, createdTime=Sun Feb 19 20:04:31 CST 2023, time=2023-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113511, encodeId=75e8211351115, content=偏重的研究方向：肿瘤 经验分享：这个杂志最近是不是有点慢啊，12.21 1 reviewer accepted，1.7 2reviewers accepted，然后就没有动静了，要不要写信催一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc268448312, createdName=ms1000000584175178, createdTime=Tue Feb 07 18:01:05 CST 2023, time=2023-02-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2104949, encodeId=30da210494901, content=偏重的研究方向：肿瘤 经验分享：11.29投稿，现在还在editor appointed……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc268448312, createdName=ms1000000584175178, createdTime=Thu Dec 08 17:36:58 CST 2022, time=2022-12-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2113155, encodeId=88c12113155d5, content=偏重的研究方向：肿瘤 经验分享：这个期刊发出去的推荐审稿邮件怎么总是接收不到啊，大家有这个情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea6a8386516, createdName=ms3000002119116075, createdTime=Sun Feb 05 18:21:05 CST 2023, time=2023-02-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113154, encodeId=9765211315416, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：为什么这个期刊发出去的邀请审稿的邮件都收不到啊，我推荐的审稿人编辑表示已经邀请了，但是人家说没收到邮件。奇怪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea6a8386516, createdName=ms3000002119116075, createdTime=Sun Feb 05 18:09:47 CST 2023, time=2023-02-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2111036, encodeId=2cfe2111036f7, content=好慢啊，无语了，两个月还没有修回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff96408430, createdName=ms5000000443448137, createdTime=Fri Jan 20 23:58:25 CST 2023, time=2023-01-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2104156, encodeId=286b210415611, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：有大佬知道为啥我的技术审核那步一个月了没动静。问编辑，编辑说没收到任何投稿。这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d688419494, createdName=ms4000002066444752, createdTime=Sat Dec 03 22:47:34 CST 2022, time=2022-12-03, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1240483, encodeId=d085124048302, content=除了大修过程中出了一点小问题，没收到修稿邮件沟通了10天左右，其他的还是挺快的，文章已接收，可以毕业啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=231b6472494, createdName=ms3000000539853394, createdTime=Tue Aug 23 10:55:35 CST 2022, time=2022-08-23, status=1, ipAttribution=)]

2023-01-20 ms5000000443448137 来自河南省

好慢啊，无语了，两个月还没有修回

26 0

[GetPortalCommentsPageByObjectIdResponse(id=1081922, encodeId=0366108192243, content=偏重的研究方向：肿瘤 经验分享：我的文章13号接收的，回来看评论，很多朋友都在问参考文献格式怎么下，说实话，到现在文章被接收我都不知道哪里下，我当时投稿的时候也是找了半天没找到，后来索性找了个施普林格旗下比较类似的文献格式，然后用endnote编辑成JOCR这个样子的，然后投稿了，到现在接收了也没有什么问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5bc5555629, createdName=解忧, createdTime=Sun Dec 19 22:32:54 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218438, encodeId=49f11218438ff, content=偏重的研究方向：肿瘤;眼科 经验分享：2022.5.5晚10点投稿 2022.5.6 Quality check passed , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d564883189, createdName=18344b9fa1m, createdTime=Tue May 10 13:43:22 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115429, encodeId=695221154290a, content=偏重的研究方向：肿瘤学;肝癌 经验分享：这个接收之后多久通知排版交钱啊，多久能见刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea6a8386516, createdName=ms3000002119116075, createdTime=Sun Feb 19 20:04:31 CST 2023, time=2023-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113511, encodeId=75e8211351115, content=偏重的研究方向：肿瘤 经验分享：这个杂志最近是不是有点慢啊，12.21 1 reviewer accepted，1.7 2reviewers accepted，然后就没有动静了，要不要写信催一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc268448312, createdName=ms1000000584175178, createdTime=Tue Feb 07 18:01:05 CST 2023, time=2023-02-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2104949, encodeId=30da210494901, content=偏重的研究方向：肿瘤 经验分享：11.29投稿，现在还在editor appointed……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc268448312, createdName=ms1000000584175178, createdTime=Thu Dec 08 17:36:58 CST 2022, time=2022-12-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2113155, encodeId=88c12113155d5, content=偏重的研究方向：肿瘤 经验分享：这个期刊发出去的推荐审稿邮件怎么总是接收不到啊，大家有这个情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea6a8386516, createdName=ms3000002119116075, createdTime=Sun Feb 05 18:21:05 CST 2023, time=2023-02-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113154, encodeId=9765211315416, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：为什么这个期刊发出去的邀请审稿的邮件都收不到啊，我推荐的审稿人编辑表示已经邀请了，但是人家说没收到邮件。奇怪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea6a8386516, createdName=ms3000002119116075, createdTime=Sun Feb 05 18:09:47 CST 2023, time=2023-02-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2111036, encodeId=2cfe2111036f7, content=好慢啊，无语了，两个月还没有修回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff96408430, createdName=ms5000000443448137, createdTime=Fri Jan 20 23:58:25 CST 2023, time=2023-01-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2104156, encodeId=286b210415611, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：有大佬知道为啥我的技术审核那步一个月了没动静。问编辑，编辑说没收到任何投稿。这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d688419494, createdName=ms4000002066444752, createdTime=Sat Dec 03 22:47:34 CST 2022, time=2022-12-03, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1240483, encodeId=d085124048302, content=除了大修过程中出了一点小问题，没收到修稿邮件沟通了10天左右，其他的还是挺快的，文章已接收，可以毕业啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=231b6472494, createdName=ms3000000539853394, createdTime=Tue Aug 23 10:55:35 CST 2022, time=2022-08-23, status=1, ipAttribution=)]

2022-12-03 ms4000002066444752 来自吉林省

审稿速度:1.0
偏重的研究方向：肿瘤
经验分享：有大佬知道为啥我的技术审核那步一个月了没动静。问编辑，编辑说没收到任何投稿。这是什么情况

35 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1081922, encodeId=0366108192243, content=偏重的研究方向：肿瘤 经验分享：我的文章13号接收的，回来看评论，很多朋友都在问参考文献格式怎么下，说实话，到现在文章被接收我都不知道哪里下，我当时投稿的时候也是找了半天没找到，后来索性找了个施普林格旗下比较类似的文献格式，然后用endnote编辑成JOCR这个样子的，然后投稿了，到现在接收了也没有什么问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5bc5555629, createdName=解忧, createdTime=Sun Dec 19 22:32:54 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218438, encodeId=49f11218438ff, content=偏重的研究方向：肿瘤;眼科 经验分享：2022.5.5晚10点投稿 2022.5.6 Quality check passed , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=31, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d564883189, createdName=18344b9fa1m, createdTime=Tue May 10 13:43:22 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115429, encodeId=695221154290a, content=偏重的研究方向：肿瘤学;肝癌 经验分享：这个接收之后多久通知排版交钱啊，多久能见刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea6a8386516, createdName=ms3000002119116075, createdTime=Sun Feb 19 20:04:31 CST 2023, time=2023-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113511, encodeId=75e8211351115, content=偏重的研究方向：肿瘤 经验分享：这个杂志最近是不是有点慢啊，12.21 1 reviewer accepted，1.7 2reviewers accepted，然后就没有动静了，要不要写信催一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc268448312, createdName=ms1000000584175178, createdTime=Tue Feb 07 18:01:05 CST 2023, time=2023-02-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2104949, encodeId=30da210494901, content=偏重的研究方向：肿瘤 经验分享：11.29投稿，现在还在editor appointed……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc268448312, createdName=ms1000000584175178, createdTime=Thu Dec 08 17:36:58 CST 2022, time=2022-12-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2113155, encodeId=88c12113155d5, content=偏重的研究方向：肿瘤 经验分享：这个期刊发出去的推荐审稿邮件怎么总是接收不到啊，大家有这个情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea6a8386516, createdName=ms3000002119116075, createdTime=Sun Feb 05 18:21:05 CST 2023, time=2023-02-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2113154, encodeId=9765211315416, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：为什么这个期刊发出去的邀请审稿的邮件都收不到啊，我推荐的审稿人编辑表示已经邀请了，但是人家说没收到邮件。奇怪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea6a8386516, createdName=ms3000002119116075, createdTime=Sun Feb 05 18:09:47 CST 2023, time=2023-02-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2111036, encodeId=2cfe2111036f7, content=好慢啊，无语了，两个月还没有修回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff96408430, createdName=ms5000000443448137, createdTime=Fri Jan 20 23:58:25 CST 2023, time=2023-01-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2104156, encodeId=286b210415611, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：有大佬知道为啥我的技术审核那步一个月了没动静。问编辑，编辑说没收到任何投稿。这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d688419494, createdName=ms4000002066444752, createdTime=Sat Dec 03 22:47:34 CST 2022, time=2022-12-03, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1240483, encodeId=d085124048302, content=除了大修过程中出了一点小问题，没收到修稿邮件沟通了10天左右，其他的还是挺快的，文章已接收，可以毕业啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=231b6472494, createdName=ms3000000539853394, createdTime=Tue Aug 23 10:55:35 CST 2022, time=2022-08-23, status=1, ipAttribution=)]

2022-08-23 ms3000000539853394

除了大修过程中出了一点小问题，没收到修稿邮件沟通了10天左右，其他的还是挺快的，文章已接收，可以毕业啦

36 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务